Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,476.00    36.00 (2.50%)
Bid:
1,470.00
Ask:
1,478.00
Spread: 8.00 (0.544%)
Market Cap: £505.34m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Significant Contract Win

23 Mar 2017 07:00

RNS Number : 2611A
Craneware plc
23 March 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Significant Contract Win

 

23 March 2017 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce a significant new contract with a large hospital operator in the US.

 

This win, with an existing customer, adds further Value Cycle solutions and related services to a seven year contract originally announced in April 2014. The contract is expected to deliver a further $3.7m of revenue over this new seven year term as the hospital network rolls out these additional solutions across its facilities and $1.5m of additional revenue as the contract for the currently implemented solutions is extended to run co-terminus to this amendment.

 

In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from this contract will be recognised over future periods, adding to the Group's long term visibility of revenue under contract.

 

Keith Neilson, CEO of Craneware plc, commented, "The strategic importance of Craneware's Value Cycle solutions allow us to add new customers and deepen our relationship with our existing customers as both groups address the challenges resulting from the continued evolution to the new value based re-imbursement environment. The extension of the solution set provided to this customer and increasing the duration of the original contract underlines the value our solutions bring to our customers. We have a very positive relationship with our customers, demonstrating sustainable value; we now look forward to this extension of our working relationship with this customer to over a decade."

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

George Sellar

Hilary Buchanan

Robyn McConnachie

Josh Royston

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGMGZFMZVGNZZ
Date   Source Headline
15th Apr 20104:12 pmRNSBlocklisting Interim Review
5th Mar 201011:02 amRNSDividend Currency Election
22nd Feb 20107:01 amRNSContract Win
22nd Feb 20107:00 amRNSInterim Results
4th Feb 20105:17 pmRNSHolding(s) in Company
25th Jan 201012:49 pmRNSHolding(s) in Company
18th Jan 20107:00 amRNSTrading Update
23rd Dec 20097:01 amRNSGrant of Options
22nd Dec 20097:00 amRNSIntermountain Healthcare Selects Craneware
19th Nov 20093:11 pmRNSResult of AGM
19th Nov 20097:00 amRNSAGM Statement
6th Nov 20091:41 pmRNSDividend Currency Election
21st Oct 20092:46 pmRNSBlocklisting Interim Review
20th Oct 20097:00 amRNSNotice of AGM
1st Oct 200912:39 pmRNSPosting of Annual Report and Accounts
25th Sep 20097:00 amRNSContract Win
18th Sep 200911:51 amRNSDirector/PDMR Shareholding
7th Sep 20097:00 amRNSFinal Results
26th Aug 20097:00 amRNSNotice of Results
6th May 20097:00 amRNSDividend Currency Election
27th Apr 20097:00 amRNSAppointment of Non-Executive Director
16th Apr 200912:44 pmRNSBlocklisting Interim Review
14th Apr 20097:00 amRNSAgreement with US healthcare alliance
26th Mar 200911:01 amRNSDirector/PDMR Shareholding
26th Mar 20097:00 amRNSDividend Declaration
27th Feb 20092:43 pmRNSDirector Shareholding
23rd Feb 20097:00 amRNSInterim Results
11th Feb 20096:23 pmRNSHolding(s) in Company
29th Jan 20097:00 amRNSNotice of Results
13th Jan 20097:00 amRNSTrading Update and Contract Win
19th Nov 200811:10 amRNSHolding(s) in Company
13th Nov 20085:43 pmRNSHolding(s) in Company
7th Nov 20083:04 pmRNSDividend Currency Election
4th Nov 20087:00 amRNSAGM Statement
31st Oct 20081:43 pmRNSHolding(s) in Company
31st Oct 20081:42 pmRNSHolding(s) in Company
24th Oct 200811:28 amRNSBlocklisting Interim Review
13th Oct 20087:00 amRNSNotice of AGM
16th Sep 20085:20 pmRNSHolding(s) in Company
15th Sep 20083:58 pmRNSHolding(s) in Company
9th Sep 20087:01 amRNSAppointment of a Director
9th Sep 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSTrading Statement
26th Jun 20088:32 amRNSRe Contract
25th Jun 20083:51 pmRNSHolding(s) in Company
24th Jun 20088:34 amRNSContract with CHE
5th Jun 200812:48 pmRNSBlocklisting Interim Review
4th Jun 200812:53 pmRNSHolding(s) in Company
29th May 20087:00 amRNSAppointment of Vice President
26th Feb 20087:01 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.